Study of tumor infiltrating lymphocytes and transforming growth factor- β as prognostic factors in breast carcinoma

International Journal of Cancer

Volumn 74, Issue 5, 1997, Pages 492-501

  Marrogi, Aizen J ^a,d   Munshi, Anupama ^a   Merogi, Athir J ^b   Ohadike, Yvonne ^a   El Habashi, Ahmed ^c   Marrogi, Olga L ^a   Freeman, Scott M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARBOR HOSPITAL   (United States)

^c NATIONAL CANCER INSTITUTE   (Egypt)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOKINE ACTIVATED KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERLEUKIN-10; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030659077     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO;2-Z     Document Type: Article

References (27)

1. BEAHRS, O.H., HENSON, D.E., HUTTER, R.V.P. and KENNEDY, B.J. (eds.), In: Manual for Staging of Cancer, American Joint Committee on Clinical Cancer, (4th ed.), pp. 149-154 (1988).
2. BOGDAN, C. and NATHAN, C., Modulation of macrophage function by transforming growth factor-beta, interleukin-4, and interleukin-10. Ann. N. Y. Acad. Sci., 685, 713-739 (1993).
3. BRAAKMAN, E., VAN DE WINKEL, J.G.J., VAN KRIMPEN, B.A., JANSZE, M. and BOLHUIS, R.L.H., CD 16 on human γδ T lymphocytes. Expression, function, and specificity for mouse IgG isotypes. Cell Immunol., 143, 97-107 (1992).
4. CAMP, B.J., DYHRMAN, S.T., MEMOLI, V.A., MOTT, L.A. and BARTH, R.J., JR., In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Ann. surg. Oncol., 3, 176-184 (1996).
5. CHIN, Y., JANSEN, J., VANDEPITTE, J., VANDENBRANDE, J., OPDEBEEK, L. and RAUS, J., Phenotypic analysis of tumor infiltrating lymphocytes from human breast cancer. Anticancer Res., 12, 1463-1466 (1992).
6. CHOMCZYNSKI, P. and SACCHI, N., Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
7. COLOMBO, M.P., MODESTI, A., PARMIANI, G. and FORM, G., Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T lymphocyte cross talk. Cancer Res., 52, 4853-1857 (1992).
8. GARFINKEL, L., BORING, C.C. and HEATH, C.W., JR., Changing trends. An overview of breast cancer incidence and mortality. Cancer, 74, 222-227 (1994).
9. GAUDIN, C., DIETRICH, P.Y., ROBACHE, S., GUILLARD, M., ESCUDIER, B., LACOMBE, M.L.T., KUMAR, A., TRIEBEL, F. and CAIGNARD, A., In vivo local expansion of clonal T cell subpopulation in renal cell carcinoma. Cancer Res., 55, 685-690 (1995).
10. GOLUMBEK, P.T., LAZENBY, A.J., LEVITSKY, H.I., JAFFEE, L.M., KARASUYAMA, H., BAKER, M. and PARDOLL, D.M., Treatment of established renal cancer by tumor cells engineered to secrete interleukin 4. Science, 254, 713-716 (1991).
11. GRIMM, E.A., ROBB, R.J., ROTH, J.A., NECKERS, L.M., LACHMAN, L.B., WILSON, D.J. and ROSENBERG, S.A., Lymphokine activated killer cell phenomenon III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J. Exp. Med, 158, 1356-1361 (1983).
12. HOUBIERS, J.G.A., NIJMAN, H.W., VAN DER BURG, S.H., DRIJFHOUT, J.W., KENEMANS, P., VAS DE VELDE, C.J., BRAND, A., MOMBURG, F., KAST, W.M. and MELIEF, C.J., In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild type p53. Europ. J. Immunol., 23, 2072-2077 (1993).
13. HSU, D.M., RAINE, L. and FANGER, H., Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase technique. J. Histochem. Cytochem. 9, 577 (1981).
14. MEROGI, A.J., MARROGI, A.J., RAMESH, R., ROBINSON, W.R., FERMIN, C.D. and FREEMAN, S.M., Tumor host interaction: analysis of cytokines, growth factors, and tumor infiltrating lymphocytes in ovarian carcinomas. Hum Pathol., 28, 321-331 (1997).
15. MOORE, K.W.A., O'GARRA, R., DE WAAL, MALEFYT, R., VIEIRA, P. and MOSMANN, T.R., Interleukin-10. Ann. Rev. Immunol., 11, 165-190 (1993).
16. MULE, J.J., SHU, S. and ROSENBERG, S.A., The anti-tumor efficacy of lymphokine activated killer cells and recombinant interleukin 2 in vivo. J. Immunol., 135, 646-652 (1985).
17. MURRAY, P.A., BARRETT-LEE, P., TRAVERS, M., LUQMANI, Y., POWLES, T. and COOMBES, R.C., The prognostic significance of transforming growth factors in human breast cancer. Brit. J. Cancer, 67, 1408-1412 (1993).
18. NOURI, A.M., HUSSAIN, R.F., DOS SANTOS, A.V., MANSOURI, M. and OLIVER, R.T., Intensity of class I antigen expression in tumor cell lines and its relevance to the efficiency of non-MHC restricted killing. Brit. J. Cancer, 67, 1223-1228 (1993).
19. O'MAHONY, A.M., O'SULLIVAN, G.C., O'CONNELL, J., COTTER, T.G. and COLLINS, J.K., An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J. Immunol., 151, 4847-4856 (1995).
20. O'SULLIVAN, C., and LEWIS, C.E., Tumor associated leucocytes: friends or foes in breast carcinoma. J. Pathol., 172, 229-235 (1994).
21. + ovarian cancers. J. Immunol., 152, 4993-4999 (1994).
22. RAMESH, R., MARROGI, A.J., MUNSHI, A., ABBOUD, C.N. and FREEMAN, S.M., In vivo analysis of the "bystander effect": a cytokine cascade. Exp. Hematol., 24, 829-838 (1996).
23. 2 microglobulin in metastatic melanomas from five patients receiving immunotherapy. J. nat. Cancer Inst., 88, 100-108 (1996).
24. SHI, S.R., CHAIWUN, B., YOUNG, L., COTE, R.J. and TAYLOR, C.R., Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J. Histochem. Cytochem., 41, 1599-1604 (1993).
25. SUZUKI, K., ONO, T. and TAKAHASHI, K., Inhibition of DNA synthesis by TGF-β1 coincides with inhibition of phosphorylation and cytoplasmic translocation of p53. Biochem. Biophys. Res. Comm., 183, 1175-1183 (1992).
26. TAKAGI, S., CHEN, K., SCHWARZ, R., IWATSUKI, S., HERBERMAN, R.B. and WHITESIDE, T.L., Functional and phenotypic analysis of tumor infiltrating lymphocytes isolated from human primary metastatic liver tumors and cultured in recombinant interleukin-2. Cancer, 63, 102-111 (1989).
27. TOI, M., NAKAMURA, T., MUKAIDA, H., WADA, T., OSAKI, A., YAMADA, H., TOGE, T., NIIMOTO, M. and HATTORI, T., Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer. Cancer, 65, 1980-1985 (1990).